{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T14:16:00Z","timestamp":1790345760011,"version":"4.1.0"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.ejphar.2024.176600","type":"journal-article","created":{"date-parts":[[2024,4,19]],"date-time":"2024-04-19T06:06:17Z","timestamp":1713506777000},"page":"176600","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["Dabrafenib mitigates the neuroinflammation caused by ferroptosis in experimental autoimmune encephalomyelitis by up regulating Axl receptor"],"prefix":"10.1016","volume":"973","author":[{"given":"Ning","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wuhan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengjiao","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoling","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manxia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2024.176600_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellimm.2022.104580","article-title":"CC chemokine receptor 5 antagonist alleviates inflammation by regulating IFN-\u03b3\/IL-10 and STAT4\/Smad3 signaling in a mouse model of autoimmune encephalomyelitis","volume":"379","author":"Ahmad","year":"2022","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.ejphar.2024.176600_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2023.104658","article-title":"S3I-201, a selective stat3 inhibitor, ameliorates clinical symptoms in a mouse model of experimental autoimmune encephalomyelitis through the regulation of multiple intracellular signalling in Th1, Th17, and treg cells","volume":"73","author":"Ahmad","year":"2023","journal-title":"Mult Scler Relat Disord"},{"key":"10.1016\/j.ejphar.2024.176600_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2023.176086","article-title":"MAP kinase inhibitor PD98059 regulates Th1, Th9, Th17, and natural T regulatory cells in an experimental autoimmune encephalomyelitis mouse model of multiple sclerosis","volume":"959","author":"Ahmad","year":"2023","journal-title":"Eur. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.ejphar.2024.176600_bib4","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/glia.23113","article-title":"The TAM receptor Tyro3 regulates myelination in the central nervous system","volume":"65","author":"Akkermann","year":"2017","journal-title":"Glia"},{"key":"10.1016\/j.ejphar.2024.176600_bib5","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.molimm.2022.02.017","article-title":"CCR1 antagonist ameliorates experimental autoimmune encephalomyelitis by inhibition of Th9\/Th22-related markers in the brain and periphery","volume":"144","author":"Al-Mazroua","year":"2022","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.ejphar.2024.176600_bib6","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.brainresbull.2023.01.003","article-title":"Mitogen-activated protein kinase inhibitor PD98059 improves neuroimmune dysfunction in experimental autoimmune encephalomyelitis in SJL\/J mice through the inhibition of nuclear factor-kappa B signaling in B cells","volume":"194","author":"Alomar","year":"2023","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.ejphar.2024.176600_bib7","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.nbd.2014.09.016","article-title":"Focal disturbances in the blood-brain barrier are associated with formation of neuroinflammatory lesions","volume":"74","author":"Alvarez","year":"2015","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.ejphar.2024.176600_bib8","article-title":"The MAP kinase inhibitor PD98059 reduces chromosomal instability in the autoimmune encephalomyelitis SJL\/J-mouse model of multiple sclerosis","volume":"861\u2013862","author":"Attia","year":"2021","journal-title":"Mutat. Res. Genet. Toxicol. Environ. Mutagen"},{"key":"10.1016\/j.ejphar.2024.176600_bib9","first-page":"2209","volume":"vol. 66","author":"Blades","year":"2018"},{"key":"10.1016\/j.ejphar.2024.176600_bib10","volume":"vol. 218","author":"Chen","year":"2021"},{"key":"10.1016\/j.ejphar.2024.176600_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106122","article-title":"BRD4770 functions as a novel ferroptosis inhibitor to protect against aortic dissection","volume":"177","author":"Chen","year":"2022","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ejphar.2024.176600_bib12","first-page":"205","volume":"vol. 14","author":"Chen","year":"2023"},{"issue":"5","key":"10.1016\/j.ejphar.2024.176600_bib13","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S1474-4422(18)30499-X","article-title":"Global, regional, and national burden of neurological disorders, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016","volume":"18","author":"Collaborators","year":"2019","journal-title":"Lancet Neurol."},{"issue":"4","key":"10.1016\/j.ejphar.2024.176600_bib14","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1111\/j.1476-5381.2011.01302.x","article-title":"Experimental autoimmune encephalomyelitis (EAE) as a model for multiple sclerosis (MS)","volume":"164","author":"Constantinescu","year":"2011","journal-title":"Br. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.ejphar.2024.176600_bib15","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S1474-4422(10)70007-7","article-title":"Combination therapy in multiple sclerosis","volume":"9","author":"Conway","year":"2010","journal-title":"Lancet Neurol."},{"issue":"5","key":"10.1016\/j.ejphar.2024.176600_bib16","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","article-title":"Ferroptosis: an iron-dependent form of nonapoptotic cell death","volume":"149","author":"Dixon","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.ejphar.2024.176600_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114593","article-title":"Mesenchymal stem cell-derived exosomal microRNA-367-3p alleviates experimental autoimmune encephalomyelitis via inhibition of microglial ferroptosis by targeting EZH2","volume":"162","author":"Fan","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejphar.2024.176600_bib18","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.neuint.2017.01.004","article-title":"Ferroptosis and cell death mechanisms in Parkinson's disease","volume":"104","author":"Guiney","year":"2017","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.ejphar.2024.176600_bib19","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/725370","article-title":"Inflammation, iron, energy Failure, and oxidative stress in the pathogenesis of multiple sclerosis","volume":"2015","author":"Haider","year":"2015","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"7","key":"10.1016\/j.ejphar.2024.176600_bib20","doi-asserted-by":"crossref","DOI":"10.7326\/0003-4819-160-7-201404010-01004","article-title":"In the clinic. Multiple sclerosis","volume":"160","author":"Harrison","year":"2014","journal-title":"Ann. Intern. Med."},{"issue":"10","key":"10.1016\/j.ejphar.2024.176600_bib21","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s11910-014-0485-1","article-title":"Remyelination and multiple sclerosis: therapeutic approaches and challenges","volume":"14","author":"Hartley","year":"2014","journal-title":"Curr. Neurol. Neurosci. Rep."},{"issue":"12","key":"10.1016\/j.ejphar.2024.176600_bib22","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1016\/j.amjmed.2020.05.049","article-title":"Treatment of multiple sclerosis: a Review","volume":"133","author":"Hauser","year":"2020","journal-title":"Am. J. Med."},{"key":"10.1016\/j.ejphar.2024.176600_bib23","first-page":"426","volume":"vol. 148","author":"Hu","year":"2019"},{"key":"10.1016\/j.ejphar.2024.176600_bib24","author":"Li"},{"key":"10.1016\/j.ejphar.2024.176600_bib25","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2020.590884","article-title":"Rapamycin alleviates the symptoms of multiple sclerosis in experimental autoimmune encephalomyelitis (EAE) through mediating the TAM-TLRs-SOCS pathway","volume":"11","author":"Li","year":"2020","journal-title":"Front. Neurol."},{"key":"10.1016\/j.ejphar.2024.176600_bib26","first-page":"913","volume":"vol. 19","author":"Luoqian","year":"2022"},{"issue":"3","key":"10.1016\/j.ejphar.2024.176600_bib27","doi-asserted-by":"crossref","DOI":"10.3390\/nu11030648","article-title":"Hesperetin, a Citrus Flavonoid, Attenuates LPS-induced neuroinflammation, Apoptosis and memory Impairments by Modulating TLR4\/NF-\u03baB signaling","volume":"11","author":"Muhammad","year":"2019","journal-title":"Nutrients"},{"issue":"3","key":"10.1016\/j.ejphar.2024.176600_bib28","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1021\/ml4000063","article-title":"Discovery of dabrafenib: a selective inhibitor of raf kinases with Antitumor activity against B-Raf-Driven tumors","volume":"4","author":"Rheault","year":"2013","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejphar.2024.176600_bib29","first-page":"12","volume":"vol. 26","author":"Ryan","year":"2023"},{"key":"10.1016\/j.ejphar.2024.176600_bib30","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.pharmthera.2018.03.002","article-title":"The role of TAM family receptors and ligands in the nervous system: from development to pathobiology","volume":"188","author":"Shafit-Zagardo","year":"2018","journal-title":"Pharmacol. Ther."},{"issue":"2","key":"10.1016\/j.ejphar.2024.176600_bib31","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1093\/cei\/uxac017","article-title":"Autophagy modulation in multiple sclerosis and experimental autoimmune encephalomyelitis","volume":"209","author":"Shen","year":"2022","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.ejphar.2024.176600_bib32","doi-asserted-by":"crossref","first-page":"271","DOI":"10.3389\/fnagi.2019.00271","article-title":"Role of microglial cells in Alzheimer's disease Tau Propagation","volume":"11","author":"\u0160pani\u0107","year":"2019","journal-title":"Front. Aging Neurosci."},{"issue":"8","key":"10.1016\/j.ejphar.2024.176600_bib33","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/nrneurol.2014.118","article-title":"Iron in multiple sclerosis: roles in neurodegeneration and repair","volume":"10","author":"Stephenson","year":"2014","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.ejphar.2024.176600_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110108","article-title":"The emerging role of ferroptosis in inflammation","volume":"127","author":"Sun","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejphar.2024.176600_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2022.136821","article-title":"Curcumin regulates anti-inflammatory responses by AXL\/JAK2\/STAT3 signaling pathway in experimental autoimmune encephalomyelitis","volume":"787","author":"Sun","year":"2022","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ejphar.2024.176600_bib36","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.molimm.2023.05.005","article-title":"AXL-Induced Autophagy mitigates experimental autoimmune encephalomyelitis by suppressing microglial inflammation via the PI3K\/AKT\/mTOR signaling pathway","volume":"159","author":"Sun","year":"2023","journal-title":"Mol. Immunol."},{"issue":"9","key":"10.1016\/j.ejphar.2024.176600_bib37","doi-asserted-by":"crossref","DOI":"10.3390\/nu10091173","article-title":"Impact of inflammation on ferritin, Hepcidin and the Management of iron deficiency anemia in Chronic Kidney disease","volume":"10","author":"Ueda","year":"2018","journal-title":"Nutrients"},{"issue":"22","key":"10.1016\/j.ejphar.2024.176600_bib38","first-page":"3974","article-title":"In silico drug screening by using genome-wide association study data repurposed dabrafenib, an anti-melanoma drug, for Parkinson's disease","volume":"27","author":"Uenaka","year":"2018","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ejphar.2024.176600_bib39","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2021.660523","article-title":"Microglia in health and disease: the Strength to Be Diverse and reactive","volume":"15","author":"Uriarte Huarte","year":"2021","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.ejphar.2024.176600_bib40","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/1742-2094-8-49","article-title":"Loss of the receptor tyrosine kinase Axl leads to enhanced inflammation in the CNS and delayed removal of myelin debris during experimental autoimmune encephalomyelitis","volume":"8","author":"Weinger","year":"2011","journal-title":"J. Neuroinflammation"},{"issue":"2","key":"10.1016\/j.ejphar.2024.176600_bib41","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/83960","article-title":"Specific function of B-Raf in mediating survival of embryonic motoneurons and sensory neurons","volume":"4","author":"Wiese","year":"2001","journal-title":"Nat. Neurosci."},{"issue":"1\u20132","key":"10.1016\/j.ejphar.2024.176600_bib42","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.cell.2013.12.010","article-title":"Regulation of ferroptotic cancer cell death by GPX4","volume":"156","author":"Yang","year":"2014","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.ejphar.2024.176600_bib43","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1038\/nn1898","article-title":"Raf kinase signaling functions in sensory neuron differentiation and axon growth in vivo","volume":"10","author":"Zhong","year":"2007","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.ejphar.2024.176600_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2021.113828","article-title":"Inhibition of TLR4 prevents hippocampal hypoxic-ischemic injury by regulating ferroptosis in neonatal rats","volume":"345","author":"Zhu","year":"2021","journal-title":"Exp. Neurol."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299924002887?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299924002887?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,4]],"date-time":"2024-05-04T11:02:41Z","timestamp":1714820561000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299924002887"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":44,"alternative-id":["S0014299924002887"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2024.176600","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dabrafenib mitigates the neuroinflammation caused by ferroptosis in experimental autoimmune encephalomyelitis by up regulating Axl receptor","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2024.176600","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"176600"}}